Showing results (2061-2070 of 6,775) with videos related to
Sort By:
Pageof 678
Clinical Therapeutics|January 1, 1987
Responses to nifedipine by patients with Raynaud's disease and Raynaud's phenomenon secondary to another diseaseA Riccio, A Del Puente, C Farinaro, et al.Clinical Therapeutics|December 6, 2022
Edaravone for Acute Ischemic Stroke: A Systematic Review and Meta-analysisKun Zhao, Guang-Zong Li, Liu-Yan Nie, et al.Clinical Therapeutics|November 24, 2022
Clinical Practice Guideline for the Therapeutic Drug Monitoring of Voriconazole in Non-Asian and Asian Adult Patients: Consensus Review by the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug MonitoringYoshio Takesue, Yuki Hanai, Kazutaka Oda, et al.Clinical Therapeutics|January 5, 2023
Effect of Glucagon-like Peptide-1 Receptor Agonists on Prognosis of Heart Failure and Cardiac Function: A Systematic Review and Meta-analysis of Randomized Controlled TrialsLiu Huixing, Fu Di, Peng DaoquanClinical Therapeutics|January 22, 2023
Hepatotoxicity Associated with Immune Checkpoint Inhibitors in Clinical Practice: A Study Leveraging Data from the US Food and Drug Administration's Adverse Event Reporting SystemHaozhou Wang, Hui Yang, Xiaoguang Zhou, et al.Clinical Therapeutics|December 24, 2022
A Systematic Review of Systematic Reviews and a Pooled Meta-Analysis on Complementary and Integrative Medicine for Improving Cancer-Related FatigueSilvia Belloni, Massimo Bonucci, Cristina Arrigoni, et al.Clinical Therapeutics|December 29, 2022
Computed Analysis of Retinal Vascular Growth After Bevacizumab Treatment of Retinopathy of Prematurity Until Age 3 YearsJ D Hammer, Henry Nguyen, Jacqueline Palmer, et al.Clinical Therapeutics|June 29, 2021
Applying the Toxicity Index to Patient-Reported Symptom Data: An Example Using the European Organization for Research and Treatment of Cancer Colorectal Cancer-Specific Quality of Life QuestionnaireRon D Hays, Patricia A Ganz, Karen L Spritzer, et al.Clinical Therapeutics|June 14, 2021
A Higher Dose of Dasatinib May Increase the Possibility of Crossing the Blood-brain Barrier in the Treatment of Patients With Philadelphia Chromosome-positive Acute Lymphoblastic LeukemiaXiaoyuan Gong, Le Li, Hui Wei, et al.Pageof 678